Hormonal
Model: V300
The V300 is a compact, high-speed immunofluorescence analyzer designed for accurate, rapid detection of a wide range of biomarkers. Utilizing advanced fluorescence immunoassay (IFA) technology, it delivers reliable qualitative and quantitative results in under 10 seconds. With support for multiple sample types, built-in data connectivity, and user-friendly Android interface, the V300 is ideal for clinical diagnostics, research laboratories, and point-of-care settings.
Application
Where V300 makes a difference.
- Emergency Laboratory
- Clinical Department
- Medical Center
- Examination Center
- Research Laboratory
Testing Speed
<10s
Result in under 10 seconds
Every test. Every time.
Immunofluorescence Reagent
A comprehensive
biomarker panel.
The V300 supports a wide range of immunofluorescence reagent cards — covering inflammation, hormones, cardiac markers, oncology, infectious disease, and more.
Inflammation
Sex Hormone
Thyroid Hormone
Infectious Disease
Cardiac Marker
Tumor Marker
Diabetes
Growth Hormone
Kidney
Stomach Health
Anaemia
Nerve
Rheumatism
Others
Technical Specs
Every detail matters.
Principle
Works based on fluorescence immunoassay to detect substances in samples. |
Sample Type
Whole Blood, Serum, Plasma, Urine, Cerebrospinal Fluid (CSF), Tissue Biopsy, Saliva, Bronchoalveolar Lavage (BAL), Synovial Fluid, Pleural Fluid, |
Screen Size
8.1 inch touch screen |
Power Supply
AC 100–240V, 50/60Hz |
Operating System
Android |
Weight
3.00 KG |
Dimension
325 mm x 159 mm * 202 mm |
Testing Channel
Single |
Testing Speed
Time for one test < 10s |
Testing Items
255 |
Item PerCard
Multiple items per card supported |
Data Storage Volume
10000 |
Language Interface
Chinese, English (customizable) |
Printer
Built-in thermal printer, supports external printers |
Reagent CardCode
Bar code, QR code (customized) |
Applicable Card Type
ID card |
| Category | Test Item | Item No | Sample | Reaction Time | Linearity Range | Refrence |
|---|---|---|---|---|---|---|
| Infection | CRP | SA.02.00002 (SEMI) / SJ.02.00002 (AUTO) | Serum / Plasma | 3 min | 0.5-200 mg/L | 10 > mg/L |
| Infection | PCT | SA.02.00004 (SEMI) / SJ.02.00004 (AUTO) | Serum / Plasma | 15 min | 0.1-100 ng/mL | 0.5 > ng/mL |
| Infection | SAA | SA.02.00005 (SEMI) / SJ.02.00005 (AUTO) | Serum / Plasma | 15 min | 2.0-100 mg/mL | 10 > mg/mL |
| Infection | IL-6 | SA.02.00006 (SEMI) / SJ.02.00006 (AUTO) | Serum / Plasma | 15 min | 3.0-4000 pg/mL | 7.5 > pg/mL |
| Infection | CRP / SAA | SA.02.00007 (SEMI) / SJ.02.00007 (AUTO) | Serum / Plasma | 15 min | CRP: 0.5-150 mg/L / SAA: 0.5-300 mg/L | CRP < 8.28 mg/L / SAA < 10 mg/L |
| Infection | PCT / IL-6 | SA.02.00008 (SEMI) / SJ.02.00008 (AUTO) | Serum / Plasma | 15 min | IL-6: 10-1000 pg/mL / PCT: 0.1-40 ng/mL | IL-6 < 15 pg/mL / PCT < 0.5 ng/mL |
| Infection | HBP / PCT | SA.02.00053 (SEMI) / SJ.02.00053 (AUTO) | Plasma | 15 min | HBP: 1-200 ng/mL / PCT: 0.05-50 ng/mL | HBP < 15 ng/mL / PCT < 0.5 ng/mL |
| Infection | HBP | SA.02.00054 (SEMI) / SJ.02.00054 (AUTO) | Plasma | 15 min | 5-300 ng/mL | 15 > ng/mL |
| Sex Hormone | PROG | SA.02.00009 (SEMI) / SJ.02.00009 (AUTO) | Serum / Plasma | 15 min | 1.2-120 nmol/L | Follicular: 0.6–1.9 nmol/L; Oviposit: 0.95–6.68; Luteal: 6.8–72; Pregnancy 1st: 48.97–190.8; Menopause: 0.32–2.0; Male: 0.31–2.67 |
| Sex Hormone | FSH | SA.02.00010 (SEMI) / SJ.02.00010 (AUTO) | Serum / Plasma | 15 min | 2-100 IU/L | Follicular: 1.5–7.5; Oviposit: 2.8–12.5; Luteal: 1.8–5.0; After menopause: 15.0–76.0; Male: 1.25–19.62 |
| Sex Hormone | LH | SA.02.00011 (SEMI) / SJ.02.00011 (AUTO) | Serum / Plasma | 15 min | 2-100 IU/L | Follicular: 2–12.5; Oviposit: 13–106; Luteal: 0.5–10.5; After menopause: 7.6–25.2; Male: 1.15–6.85 |
| Sex Hormone | β-HCG | SA.02.00012 (SEMI) / SJ.02.00012 (AUTO) | Serum / Plasma | 15 min | 4-10000 mIU/mL | 10 > mIU/mL |
| Sex Hormone | PRL | SA.02.00013 (SEMI) / SJ.02.00013 (AUTO) | Serum / Plasma | 15 min | 40-3000 μIU/mL | Premenopausal: 74–566; Postmenopausal: 68–528; Male: 63–350 μIU/mL |
| Sex Hormone | Cor | SA.02.00014 (SEMI) / SJ.02.00014 (AUTO) | Serum / Plasma | 15 min | 0.5 μg/dL–36 μg/dL | 3.56–22.73 μg/dL |
| Sex Hormone | AMH | SA.02.00015 (SEMI) / SJ.02.00015 (AUTO) | Serum / Plasma | 15 min | 0.1-24 ng/mL | 2–14 ng/mL |
| Thyroid Hormone | TSH | SA.02.00016 (SEMI) / SJ.02.00016 (AUTO) | Serum / Plasma | 15 min | 0.1-100 μIU/mL | 0.3-5.6 μIU/mL |
| Thyroid Hormone | T3 | SA.02.00017 (SEMI) / SJ.02.00017 (AUTO) | Serum / Plasma | 15+10 min | 0.77-6.0 nmol/L | 1.34-2.73 nmol/L |
| Thyroid Hormone | T4 | SA.02.00018 (SEMI) / SJ.02.00018 (AUTO) | Serum / Plasma | 15 min | 15-300 nmol/L | 78.51-157.01 nmol/L |
| Thyroid Hormone | FT3 | SA.02.00057 (SEMI) / SJ.02.00057 (AUTO) | Serum / Plasma | 10 min | 1.6-46 pmol/L | 3.1-6.8 pmol/L |
| Thyroid Hormone | FT4 | SA.02.00058 (SEMI) / SJ.02.00058 (AUTO) | Serum / Plasma | 10 min | 3.2-77.2 pmol/L | 11.5-22.7 pmol/L |
| Cardiac Marker | CK-MB | SA.02.00001 (SEMI) / 5102.00001 (AUTO) | Serum / Plasma | 15 min | 1-100 ng/mL | CK-MB < 5 ng/mL |
| Cardiac Marker | cTnI | 51.02.00019 (SEMI) / 5102.00019 (AUTO) | Serum / Plasma | 15 min | 0.1-40 ng/mL | < 0.5 ng/mL |
| Cardiac Marker | Myo | SA.02.00020 (SEMI) / 5102.00020 (AUTO) | Serum / Plasma | 15 min | 5-400 ng/mL | < 60 ng/mL |
| Cardiac Marker | NT-proBNP | SA.02.00021 (SEMI) / 51.02.00021 (AUTO) | Serum / Plasma | 15 min | 50-20000 pg/mL | 300 pg/mL (< 75 yrs), 450 pg/mL (≥ 75 yrs) |
| Cardiac Marker | H-FABP | SA.02.00022 (SEMI) / 5102.00022 (AUTO) | Serum / Plasma | 15 min | 3-100 ng/mL | < 7 ng/mL |
| Cardiac Marker | D-Dimer | SA.02.00023 (SEMI) / 5102.00023 (AUTO) | Serum / Plasma | 15 min | 0.1-10 mg/L | < 0.5 mg/L |
| Cardiac Marker | cTnI / Myo / CK-MB (3 in 1) | SA.02.00024 (SEMI) / 5102.00024 (AUTO) | Serum / Plasma | 15 min | cTnI: 0.1-40 ng/mL, CK-MB: 1-100 ng/mL, Myo: 5-400 ng/mL | cTnI < 0.3 ng/mL, CK-MB < 5 ng/mL, Myo < 60 ng/mL |
| Cardiac Marker | cTnI / NT-proBNP | 51.02.00025 (SEMI) / 5102.00025 (AUTO) | Serum / Plasma | 15 min | cTnI: 0.1-40 ng/mL, NT-proBNP: 50-20000 pg/mL | cTnI < 0.5 ng/mL, NT-proBNP: 300 pg/mL (< 75 yrs), 450 pg/mL (≥ 75 yrs) |
| Cardiac Marker | cTnT | SA.02.00052 (SEMI) / 5102.00052 (AUTO) | Serum / Plasma / Whole Blood | 15 min | 30.0–10000.0 pg/mL | > 100 pg/mL |
| Kidney | NGAL | SA.02.00026 (SEMI) / 5102.00026 (AUTO) | Serum / Plasma | 10 min | 50-1000 ng/mL | > 60 ng/mL |
| Kidney | mAlb | SA.02.00027 (SEMI) / S102.00027 (AUTO) | Urine | 15 min | 5-300 mg/L | 0-20 mg/L |
| Kidney | CysC | SA.02.00028 (SEMI) / 5102.00028 (AUTO) | Serum / Plasma | 5 min | 0.2-10 mg/L | 0.5-1.1 mg/L |
| Kidney | β2-MG | SA.02.00029 (SEMI) / SA02.00029 (AUTO) | Serum / Plasma | 15 min | 0.3-20 mg/L | 1.0-2.7 mg/L |
| Diabetes | HbA1c | SA.02.00030 (SEMI) / SA02.00030 (AUTO) | Whole Blood | 15 min | 2-14% | 3.8 - 5.8% |
| Gastric Function | PG I | SA.02.00033 (SEMI) / 5102.00033 (AUTO) | Serum / Plasma | 15 min | 70-200 ng/mL | < 20 ng/mL |
| Gastric Function | PG I | SA.02.00033 (SEMI) / 5102.00033 (AUTO) | Serum / Plasma | 15 min | 5-200 ng/mL | 2.5-100 ng/mL |
| Gastric Function | G17 | SA.02.00056 (SEMI) / 5102.00056 (AUTO) | Serum / Plasma | 15 min | 1-50 pmol/L | 1-7 pmol/L |
| Cancer | CEA | SA02.00034 (SEMI) / 51.02.00034 (AUTO) | Serum / Plasma | 15 min | 2.5-1000 ng/mL | > 35 ng/mL |
| Cancer | AFP | SA.02.00035 (SEMI) / 51.02.00035 (AUTO) | Serum / Plasma | 15 min | 5-1000 ng/mL | > 25 ng/mL |
| Cancer | PSA | SA02.00036 (SEMI) / S1.02.00036 (AUTO) | Serum / Plasma | 15 min | 2.0-100.0 ng/mL | > 4 ng/mL |
| Cancer | DO | SA.02.00055 (SEMI) / S102.00055 (AUTO) | Serum / Plasma | 15 min | 1-20 pmol/L | > 2 pmol/L |
| Infectious Disease | SARS‑CoV‑2 Ag | SA.02.00037 (SEMI) / 51.02.00037 (AUTO) | Naso / Oropharyngeal swab | 15 min | / | / |
| Infectious Disease | Dengue IgG / IgM | SA.02.00038 (SEMI) / 51.02.00038 (AUTO) | Serum / Plasma / Whole blood | 15 min | / | / |
| Infectious Disease | SARS‑CoV‑2 / Flu A+B | SA.02.00039 (SEMI) / 51.02.00039 (AUTO) | Naso / Oropharyngeal swab | 15 min | / | / |
| Infectious Disease | SARS‑CoV‑2 IgG / IgM | SA.02.00040 (SEMI) / 51.02.00040 (AUTO) | Serum / Plasma | 15 min | / | / |
| Infectious Disease | HP‑Ab | SA.02.00041 (SEMI) / 51.02.00041 (AUTO) | Serum / Plasma | 15 min | / | / |
| Infectious Disease | HP‑Ag | SA.02.00042 (SEMI) / 51.02.00042 (AUTO) | Feces | 15 min | / | / |
| Infectious Disease | FOB | SA.02.00043 (SEMI) / 51.02.00043 (AUTO) | Feces | 15 min | / | / |
| Infectious Disease | P. falciparum / Pan | SA.02.00044 (SEMI) / 51.02.00044 (AUTO) | Whole blood | 15 min | / | / |
| Infectious Disease | RSV | SA.02.00045 (SEMI) / 51.02.00045 (AUTO) | Naso / Oropharyngeal swab | 15 min | / | / |
| Infectious Disease | Influenza A / B | SA.02.00046 (SEMI) / 51.02.00046 (AUTO) | Naso / Oropharyngeal swab | 15 min | / | / |
| Infectious Disease | Strep A | SA.02.00047 (SEMI) / 51.02.00047 (AUTO) | Naso / Oropharyngeal swab | 15 min | / | / |
| Infectious Disease | Adenovirus | SA.02.00048 (SEMI) / 51.02.00048 (AUTO) | Naso / Oropharyngeal swab | 15 min | / | / |
| Infectious Disease | Mycoplasma IgG / IgM | SA.02.00049 (SEMI) / 51.02.00049 (AUTO) | Serum / Plasma / Whole blood | 15 min | / | / |
| Infectious Disease | Influenza A / B + H1N1 | SA.02.00050 (SEMI) / 51.02.00050 (AUTO) | Naso / Oropharyngeal swab | 15 min | / | / |
| Infectious Disease | Dengue NS1 Ag | SA.02.00051 (SEMI) / 51.02.00051 (AUTO) | Serum / Plasma / Whole blood | 15 min | / | / |
| Others | 25-OH-VD | SA.02.0°D31 (SEMI) / 51.02.00031 (AUTO) | Serum / Plasma | 10 min | 8–80 ng/mL | 30–80 ng/mL |
| Others | IgE V812 | SA.02.00032 (SEMI) / 51.02.00032 (AUTO) | Serum / Plasma | 15 min | 8–1000 IU/mL | Neonatal: 0–1.5 IU/mL; <1 yr: 0–15 IU/mL; 1–5 yrs: 0–90 IU/mL; 6–9 yrs: 0–90 IU/mL; 10–15 yrs: 0–200 IU/mL; Adult: 0–100 IU/mL |
| Others | Vitamin D Related Test | SA.02.00059 (SEMI) / 51.02.00059 (AUTO) | Serum / Plasma | 15 min | 150–1500 pg/mL | 240–800 pg/mL |
| Sex Hormone | Sex Hormone HCG (GICA) | SA.03.00010 (SEMI) / S1.03.00010 (AUTO) | Urine | 5 min | ||
| Sex Hormone | LH (GICA) | SA.03.00002 (SEMI) / S1.03.00002 (AUTO) | Urine | 5 min | ||
| Infectious Disease | HP-Ab (GICA) | SA.03.00003 (SEMI) / 51.03.00003 (AUTO) | Serum / Plasma | 15 min | ||
| Infectious Disease | HP-Ag (GICA) | SA.03.00004 (SEMI) / 51.03.00004 (AUTO) | Feces | 15 min | ||
| Infectious Disease | SARS-Cov-2 (LIA) | SA.03.00005 (SEMI) / 5103.00005 (AUTO) | Naso / Oropharyngeal swab | 15 min | ||
| Infectious Disease | SARS-Cov-2 (GICA) | SA.03.00006 (SEMI) / 5103.00006 (AUTO) | Naso / Oropharyngeal swab | 15 min | ||
| Infectious Disease | Flu A / B (GICA) | SA.03.00007 (SEMI) / 51.03.00007 (AUTO) | Naso / Oropharyngeal swab | 15 min | ||
| Infectious Disease | SARS-Cov-2 / Flu A+B (GICA) | SA.03.00008 (SEMI) / 5103.00008 (AUTO) | Naso / Oropharyngeal swab | 15 min | ||
| Infectious Disease | SARS-CoV-2 IgG / IgM (GICA) | SA.03.00009 (SEMI) / 51.03.00009 (AUTO) | Serum / Plasma | 15 min | ||
| Infectious Disease | InBuenza A / B (LIA) | SA.03.00011 (SEMI) / 51.03.00011 (AUTO) | Naso / Oropharyngeal swab | 15 min | ||
| Infectious Disease | Dengue IgG / IgM (GICA) | SA.03.00012 (SEMI) / S./03.00012 (AUTO) | Serum / Plasma / Whole blood | 15 min | ||
| Infectious Disease | Dengue NS1 Ag (GICA) | SA.03.00013 (SEMI) / 51.03.00013 (AUTO) | Serum / Plasma / Whole blood | 15 min |